<?xml version="1.0"?>
<iati-activities version="2.03" generated-datetime="2023-03-09T07:33:18+00:00">
<!--Generated By AidStream-->
  <iati-activity last-updated-datetime="2023-03-09T07:33:18+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1" linked-data-uri="">
    <iati-identifier>CH-FDJP-110.162.567-FIND2021</iati-identifier>
    <reporting-org type="30" ref="CH-FDJP-110.162.567">
      <narrative>Foundation for Innovative New Diagnostics</narrative>
    </reporting-org>
    <title>
      <narrative xml:lang="en">Ensure equitable access to reliable diagnosis around the world</narrative>
    </title>
    <description type="1">
      <narrative xml:lang="en">Despite  the  ongoing  challenges  of  the  COVID-19  pandemic,  FIND  capitalized  on  its recently launched strategy and achieved its 2021 goals, delivering an average of 81% of  programmatic  performance  objectives  (versus  80%  target).  Outside  COVID,  four products  in  FIND&#x2019;s  product  development  portfolio  received  regulatory  clearance; evidence   was   generated   to   support six World   Health   Organization   (WHO) recommendations and policy documents; and 36 clinical studies were conducted, 28 of which relied on newly developed approaches to remote work and remote training. Notably, in 2021, FIND was especially focused on its role in supporting global access to COVID-19 tests and genomic sequencing, through its role in the Access to COVID-19  Tools  Accelerator Diagnostics  Pillar  (ACT-A  Dx).  In  part,  this  meant  engaging substantially with multiple global agencies, and absorbing a large injection of COVID-19 work into ongoing work across FIND&#x2019;s disease portfolio, including in pandemics threats.</narrative>
    </description>
    <participating-org ref="AU-5" type="10" role="1" crs-channel-code="11000">
      <narrative xml:lang="en">Australia - Department of  Foreign Affairs and Trade</narrative>
    </participating-org>
    <participating-org ref="DAC-1601" type="60" role="1">
      <narrative xml:lang="en">Bill &amp; Melinda Gates Foundation</narrative>
    </participating-org>
    <participating-org ref="DE-1" type="10" role="1" crs-channel-code="11000">
      <narrative xml:lang="en">Germany - Ministry for Economic Cooperation and Development</narrative>
    </participating-org>
    <participating-org type="10" role="1">
      <narrative>Department of Foreign Affairs, trade and development</narrative>
    </participating-org>
    <participating-org ref="GB-GOV-1" type="10" role="1" crs-channel-code="11000">
      <narrative xml:lang="en">UK - Foreign, Commonwealth and Development Office</narrative>
    </participating-org>
    <participating-org type="60" role="1" crs-channel-code="90000">
      <narrative>Gordon &amp; Betty Moore Foundation</narrative>
    </participating-org>
    <participating-org type="80" role="1">
      <narrative>JHPIEGO</narrative>
    </participating-org>
    <participating-org type="10" role="1">
      <narrative>Federal Ministry of Education and Research</narrative>
    </participating-org>
    <participating-org type="10" role="1" crs-channel-code="11000">
      <narrative>Mission of Kuwait to the United Nations</narrative>
    </participating-org>
    <participating-org ref="XM-DAC-7" type="10" role="1" activity-id="XM-DAC-7-PPR-4000004160" crs-channel-code="11000">
      <narrative xml:lang="en">Netherlands - Ministry of Foreign Affairs</narrative>
    </participating-org>
    <participating-org ref="NO-BRC-971277882" type="10" role="1" crs-channel-code="11000">
      <narrative xml:lang="en">Norad - Norwegian Agency for Development Cooperation</narrative>
    </participating-org>
    <participating-org ref="US-EIN-91-1157127" type="21" role="1" crs-channel-code="20000">
      <narrative xml:lang="en">PATH</narrative>
    </participating-org>
    <participating-org type="70" role="1">
      <narrative>Optum Global Solutions (India) Private Limited</narrative>
    </participating-org>
    <participating-org type="60" role="1">
      <narrative>Rockefeller Foundation</narrative>
    </participating-org>
    <participating-org type="10" role="1">
      <narrative>Ministry of Finance, Kingdom of Saudi Arabia</narrative>
    </participating-org>
    <participating-org ref="CH-4" type="10" role="1" crs-channel-code="11000">
      <narrative xml:lang="en">Switzerland - Swiss Agency for Development and Cooperation (SDC)</narrative>
    </participating-org>
    <participating-org ref="47045" type="40" role="1">
      <narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="60" role="1">
      <narrative>Trafigura Foundation</narrative>
    </participating-org>
    <participating-org ref="XM-DAC-30010" type="40" role="1">
      <narrative xml:lang="en">UNITAID</narrative>
    </participating-org>
    <participating-org ref="XM-DAC-928" type="40" role="1">
      <narrative xml:lang="en">World Health Organization (WHO)</narrative>
    </participating-org>
    <activity-status code="4"/>
    <activity-date type="4" iso-date="2021-12-31">
      <narrative xml:lang="en">End of activity</narrative>
    </activity-date>
    <activity-date type="2" iso-date="2021-01-01">
      <narrative xml:lang="en">Start of activity</narrative>
    </activity-date>
    <recipient-country code="AE" percentage="0.01"/>
    <recipient-country code="AO" percentage="0.18"/>
    <recipient-country code="AR" percentage="0.01"/>
    <recipient-country code="AT" percentage="0.0001"/>
    <recipient-country code="BD" percentage="0.22"/>
    <recipient-country code="BE" percentage="2.04"/>
    <recipient-country code="BF" percentage="0.02"/>
    <recipient-country code="BR" percentage="1.85"/>
    <recipient-country code="BW" percentage="0.4"/>
    <recipient-country code="CA" percentage="0.06"/>
    <recipient-country code="CD" percentage="0.14"/>
    <recipient-country code="CF" percentage="0.005"/>
    <recipient-country code="CH" percentage="15.47"/>
    <recipient-country code="CM" percentage="0.13"/>
    <recipient-country code="CN" percentage="0.09"/>
    <recipient-country code="DE" percentage="0.87"/>
    <recipient-country code="DK" percentage="0.08"/>
    <recipient-country code="ES" percentage="0.21"/>
    <recipient-country code="ET" percentage="0.3"/>
    <recipient-country code="FR" percentage="0.77"/>
    <recipient-country code="GB" percentage="6.57"/>
    <recipient-country code="GE" percentage="0.003"/>
    <recipient-country code="GH" percentage="0.005"/>
    <recipient-country code="GM" percentage="0.03"/>
    <recipient-country code="HK" percentage="0.01"/>
    <recipient-country code="HU" percentage="0.004"/>
    <recipient-country code="ID" percentage="0.07"/>
    <recipient-country code="IE" percentage="2.09"/>
    <recipient-country code="IL" percentage="0.01"/>
    <recipient-country code="IN" percentage="25.99"/>
    <recipient-country code="IR" percentage="0.41"/>
    <recipient-country code="IT" percentage="0.11"/>
    <recipient-country code="JP" percentage="0.02"/>
    <recipient-country code="KE" percentage="0.66"/>
    <recipient-country code="KH" percentage="0.01"/>
    <recipient-country code="KR" percentage="1.57"/>
    <recipient-country code="LA" percentage="0.002"/>
    <recipient-country code="LU" percentage="0.16"/>
    <recipient-country code="MD" percentage="0.079"/>
    <recipient-country code="ML" percentage="0.01"/>
    <recipient-country code="MW" percentage="0.43"/>
    <recipient-country code="MY" percentage="0.01"/>
    <recipient-country code="MZ" percentage="0.15"/>
    <recipient-country code="NA" percentage="0.01"/>
    <recipient-country code="NE" percentage="0.0029"/>
    <recipient-country code="NG" percentage="0.29"/>
    <recipient-country code="NL" percentage="0.51"/>
    <recipient-country code="NO" percentage="0.03"/>
    <recipient-country code="NP" percentage="0.01"/>
    <recipient-country code="PE" percentage="1.186"/>
    <recipient-country code="PH" percentage="0.06"/>
    <recipient-country code="PL" percentage="0.001"/>
    <recipient-country code="PT" percentage="0.003"/>
    <recipient-country code="RU" percentage="0.01"/>
    <recipient-country code="RW" percentage="0.24"/>
    <recipient-country code="SA" percentage="0.01"/>
    <recipient-country code="SE" percentage="0.02"/>
    <recipient-country code="SG" percentage="1.98"/>
    <recipient-country code="SN" percentage="3"/>
    <recipient-country code="SO" percentage="0.02"/>
    <recipient-country code="SS" percentage="0.003"/>
    <recipient-country code="SZ" percentage="0.032"/>
    <recipient-country code="TR" percentage="0.002"/>
    <recipient-country code="TZ" percentage="0.05"/>
    <recipient-country code="UG" percentage="0.54"/>
    <recipient-country code="US" percentage="17.84"/>
    <recipient-country code="VN" percentage="0.11"/>
    <recipient-country code="ZA" percentage="12.09"/>
    <recipient-country code="ZM" percentage="0.145"/>
    <recipient-country code="ZW" percentage="0.497"/>
    <recipient-country code="AU" percentage="0.01"/>
    <recipient-country code="BY" percentage="0.04"/>
    <sector code="3" percentage="100" vocabulary="7"/>
    <sector code="32182" percentage="72" vocabulary="1">
      <narrative xml:lang="en">R&amp;D portfolio</narrative>
    </sector>
    <sector code="12110" percentage="28" vocabulary="1">
      <narrative xml:lang="en">Access portfolio</narrative>
    </sector>
    <budget type="1" status="2">
      <period-start iso-date="2021-01-01"/>
      <period-end iso-date="2021-12-31"/>
      <value currency="USD" value-date="2021-12-31">71189586.11</value>
    </budget>
    <transaction ref="Total outgoing expenditure">
      <transaction-type code="4"/>
      <transaction-date iso-date="2021-12-31"/>
      <value currency="USD" value-date="2021-12-31">71189586</value>
      <disbursement-channel code="2"/>
    </transaction>
    <transaction ref="Total incoming funds 2021">
      <transaction-type code="1"/>
      <transaction-date iso-date="2021-12-31"/>
      <value currency="USD" value-date="2021-12-31">71189586</value>
      <description>
        <narrative>ACT-A Dx annual allocated funds</narrative>
      </description>
      <disbursement-channel code="2"/>
      <flow-type code="30"/>
    </transaction>
    <transaction ref="Dutch Ministry of Foreign Affairs (DGIS), Netherlands">
      <transaction-type code="1"/>
      <transaction-date iso-date="2021-01-01"/>
      <value currency="USD" value-date="2021-01-01">5300364.96</value>
      <description>
        <narrative xml:lang="en">Annual amount allocated from the Dutch PDP core grant</narrative>
      </description>
      <provider-org ref="XM-DAC-7" provider-activity-id="XM-DAC-7-PPR-4000004160" type="10">
        <narrative xml:lang="en">Dutch Ministry of Foreign Affairs (DGIS), Netherlands</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative xml:lang="en">Foundation for Innovative New Diagnostics</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="Dutch Ministry of Foreign Affairs (DGIS), Netherlands">
      <transaction-type code="11"/>
      <transaction-date iso-date="2021-01-01"/>
      <value currency="USD" value-date="2021-01-01">5300364.96</value>
      <description>
        <narrative xml:lang="en">ACT-A Dx annual allocated funds</narrative>
      </description>
      <provider-org ref="XM-DAC-7" provider-activity-id="XM-DAC-7-PPR-4000004160" type="10">
        <narrative xml:lang="en">ACT-A Dx annual allocated funds</narrative>
      </provider-org>
    </transaction>
  </iati-activity>
</iati-activities>
